These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 27261892)

  • 1. A novel cell-based assay to measure activity of Venezuelan equine encephalitis virus nsP2 protease.
    Campos-Gomez J; Ahmad F; Rodriguez E; Saeed MF
    Virology; 2016 Sep; 496():77-89. PubMed ID: 27261892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The crystal structure of the Venezuelan equine encephalitis alphavirus nsP2 protease.
    Russo AT; White MA; Watowich SJ
    Structure; 2006 Sep; 14(9):1449-58. PubMed ID: 16962975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic, Mutational, and Structural Studies of the Venezuelan Equine Encephalitis Virus Nonstructural Protein 2 Cysteine Protease.
    Hu X; Compton JR; Leary DH; Olson MA; Lee MS; Cheung J; Ye W; Ferrer M; Southall N; Jadhav A; Morazzani EM; Glass PJ; Marugan J; Legler PM
    Biochemistry; 2016 May; 55(21):3007-19. PubMed ID: 27030368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-inhibited State of Venezuelan Equine Encephalitis Virus (VEEV) nsP2 Cysteine Protease: A Crystallographic and Molecular Dynamics Analysis.
    Hoffka G; Lountos GT; Needle D; Wlodawer A; Waugh DS; Tőzsér J; Mótyán JA
    J Mol Biol; 2023 Mar; 435(6):168012. PubMed ID: 36792007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of a novel compound with anti-venezuelan equine encephalitis virus activity that targets the nonstructural protein 2.
    Chung DH; Jonsson CB; Tower NA; Chu YK; Sahin E; Golden JE; Noah JW; Schroeder CE; Sotsky JB; Sosa MI; Cramer DE; McKellip SN; Rasmussen L; White EL; Schmaljohn CS; Julander JG; Smith JM; Filone CM; Connor JH; Sakurai Y; Davey RA
    PLoS Pathog; 2014 Jun; 10(6):e1004213. PubMed ID: 24967809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specificity Studies of the Venezuelan Equine Encephalitis Virus Non-Structural Protein 2 Protease Using Recombinant Fluorescent Substrates.
    Bozóki B; Mótyán JA; Hoffka G; Waugh DS; Tőzsér J
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33081394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular cloning, overproduction, purification and biochemical characterization of the p39 nsp2 protease domains encoded by three alphaviruses.
    Zhang D; Tözsér J; Waugh DS
    Protein Expr Purif; 2009 Mar; 64(1):89-97. PubMed ID: 19013248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small molecule inhibitors of Ago2 decrease Venezuelan equine encephalitis virus replication.
    Madsen C; Hooper I; Lundberg L; Shafagati N; Johnson A; Senina S; de la Fuente C; Hoover LI; Fredricksen BL; Dinman J; Jacobs JL; Kehn-Hall K
    Antiviral Res; 2014 Dec; 112():26-37. PubMed ID: 25448087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteolytic cleavage of host proteins by the Group IV viral proteases of Venezuelan equine encephalitis virus and Zika virus.
    Morazzani EM; Compton JR; Leary DH; Berry AV; Hu X; Marugan JJ; Glass PJ; Legler PM
    Antiviral Res; 2019 Apr; 164():106-122. PubMed ID: 30742841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation of Asn-475 in the Venezuelan Equine Encephalitis Virus nsP2 Cysteine Protease Leads to a Self-Inhibited State.
    Compton JR; Mickey MJ; Hu X; Marugan JJ; Legler PM
    Biochemistry; 2017 Nov; 56(47):6221-6230. PubMed ID: 29064679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Approved drugs screening against the nsP1 capping enzyme of Venezuelan equine encephalitis virus using an immuno-based assay.
    Ferreira-Ramos AS; Li C; Eydoux C; Contreras JM; Morice C; Quérat G; Gigante A; Pérez Pérez MJ; Jung ML; Canard B; Guillemot JC; Decroly E; Coutard B
    Antiviral Res; 2019 Mar; 163():59-69. PubMed ID: 30639438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of nsP2 protease based cell free high throughput screening assay for evaluation of inhibitors against emerging Chikungunya virus.
    Saha A; Acharya BN; Priya R; Tripathi NK; Shrivastava A; Rao MK; Kesari P; Narwal M; Tomar S; Bhagyawant SS; Parida M; Dash PK
    Sci Rep; 2018 Jul; 8(1):10831. PubMed ID: 30018455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Old World and New World alphaviruses use different virus-specific proteins for induction of transcriptional shutoff.
    Garmashova N; Gorchakov R; Volkova E; Paessler S; Frolova E; Frolov I
    J Virol; 2007 Mar; 81(5):2472-84. PubMed ID: 17108023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homoseongomycin, a compound isolated from marine actinomycete bacteria K3-1, is a potent inhibitor of encephalitic alphaviruses.
    Lin SC; Lehman CW; Stewart AK; Panny L; Bracci N; Wright JLC; Paige M; Strangman WK; Kehn-Hall K
    Antiviral Res; 2021 Jul; 191():105087. PubMed ID: 33965437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a cell-active chikungunya virus nsP2 protease inhibitor using a covalent fragment-based screening approach.
    Merten EM; Sears JD; Leisner TM; Hardy PB; Ghoshal A; Hossain MA; Asressu KH; Brown PJ; Tse EG; Stashko MA; Li K; Norris-Drouin JL; Herring LE; Mordant AL; Webb TS; Mills CA; Barker NK; Streblow ZJ; Perveen S; Arrowsmith CH; Couñago RM; Arnold JJ; Cameron CE; Streblow DN; Moorman NJ; Heise MT; Willson TM; Popov KI; Pearce KH
    Proc Natl Acad Sci U S A; 2024 Oct; 121(42):e2409166121. PubMed ID: 39388272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification, crystallization and X-ray diffraction analysis of the C-terminal protease domain of Venezuelan equine encephalitis virus nsP2.
    Russo AT; Watowich SJ
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2006 Jun; 62(Pt 6):514-7. PubMed ID: 16754969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of novel antivirals inhibiting recognition of Venezuelan equine encephalitis virus capsid protein by the Importin α/β1 heterodimer through high-throughput screening.
    Thomas DR; Lundberg L; Pinkham C; Shechter S; DeBono A; Baell J; Wagstaff KM; Hick CA; Kehn-Hall K; Jans DA
    Antiviral Res; 2018 Mar; 151():8-19. PubMed ID: 29337164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homology modeling, molecular dynamics, e-pharmacophore mapping and docking study of Chikungunya virus nsP2 protease.
    Singh KhD; Kirubakaran P; Nagarajan S; Sakkiah S; Muthusamy K; Velmurgan D; Jeyakanthan J
    J Mol Model; 2012 Jan; 18(1):39-51. PubMed ID: 21445710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alphavirus protease inhibitors from natural sources: A homology modeling and molecular docking investigation.
    Byler KG; Collins JT; Ogungbe IV; Setzer WN
    Comput Biol Chem; 2016 Oct; 64():163-184. PubMed ID: 27387412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. mRNA Capping by Venezuelan Equine Encephalitis Virus nsP1: Functional Characterization and Implications for Antiviral Research.
    Li C; Guillén J; Rabah N; Blanjoie A; Debart F; Vasseur JJ; Canard B; Decroly E; Coutard B
    J Virol; 2015 Aug; 89(16):8292-303. PubMed ID: 26041283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.